Pham Quang X sold 2,064 shares of Cadrenal Therapeutics, Inc. at $4.42 for −$9.12k on Jun 5, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
CEO and Chairman
CEO and Chairman
Filed Jun 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$9,122.88Shares × reported price
Shares traded
2,064Common Stock
Price per share
$4.42Reported price. Read footnotes for ranges.
% of reported position traded
1.18%This security and ownership context
Holdings after
173,224Direct
Trade date
Jun 5, 2026Sell
Filed
Jun 5, 2026, 5:26 PM ET0-day reporting delay
Accession
0001213900-26-065925Code S · Transaction 100295
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 175,288 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jun 3, 2026Sell2,323$4.26−$9,895.98Trade 100292
Jun 4, 2026Sell3,898$4.41−$17,190.18Trade 100293
3 transaction rows in this filing. Joint filers share the same rows.

CVKD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CVKD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Jun 12, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 through $4.39. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 through $4.47. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.25 through $4.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and dispositive power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.